Patents by Inventor Weining Z. Robieson

Weining Z. Robieson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBCUTANEOUSLY ADMINISTERED TREATMENTS FOR ADVANCED PARKINSON'S DISEASE
    Publication number: 20240100072
    Abstract: The present disclosure relates to safe and effective subcutaneously administered treatments for advanced Parkinson's disease.
    Type: Application
    Filed: October 27, 2022
    Publication date: March 28, 2024
    Inventors: Maurizio F. Facheris, Michael Gold, Weining Z. Robieson, Melissa Vos, Amy M. Spiegel, Nahome Tezera Fisseha, Janet A. Benesh, George Liossis, Kumar Budur
  • Pharmaceutical Formulations for Subcutaneous Administration
    Publication number: 20200155578
    Abstract: The present disclosure relates to compositions of levodopa 4?-monophosphate and carbidopa 4?-monophosphate having a weight by weight ratio of about 20:1 and methods of treating Parkinson's disease and associated conditions by subcutaneous administration of such compositions.
    Type: Application
    Filed: November 15, 2019
    Publication date: May 21, 2020
    Applicant: AbbVie Inc.
    Inventors: Ehab Moussa, Matthew Rosebraugh, Feroz Jameel, Nancy Sever, Maurizio F. Facheris, Weining Z. Robieson, Charles S. Locke, Sven Stodtmann
  • NEURONAL NICOTINIC AGONIST AND METHODS OF USE
    Publication number: 20130317054
    Abstract: An embodiment relates to a selective agonist of neuronal nicotinic acetylcholine receptor ?7 subtype, a pharmaceutically suitable salt, prodrug, or a metabolite thereof, for the prevention and treatment of diseases and conditions that are mediated by nicotinic acetylcholine receptors, and methods of use thereof. Another embodiment is a method of administering a pharmaceutically effective amount of a selective agonist of neuronal nicotinic acetylcholine receptor ?7 subtype, or a pharmaceutically suitable salt, prodrug, or a metabolite thereof, to a mammal in need thereof.
    Type: Application
    Filed: March 13, 2013
    Publication date: November 28, 2013
    Applicant: ABBVIE INC.
    Inventors: George M. HAIG, Jeffrey D. BAKER, Weining Z. Robieson